Neuphoria Therapeutics (NEUP) Total Current Liabilities (2021 - 2026)
Neuphoria Therapeutics (NEUP) recorded Total Current Liabilities of $756,581 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 82.1% from $4.22 million a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Total Current Liabilities (2021 - 2026) Analysis & Trends
Starting with fiscal Q4 2021, Neuphoria Therapeutics' Total Current Liabilities history includes 12 quarters.
- Annual Total Current Liabilities has a five-year compound annual growth rate of -16.1% (FY2021 to FY2026).
- Across earlier fiscal years, Total Current Liabilities came in at $4.22 million in FY2025 (+10.2%), $3.83 million in FY2024 (+39.8%), $2.74 million in FY2023 (+13.9%) and $2.4 million in FY2022 (+32.2%).
- The fiscal Q4 2026 figure is the lowest quarterly Total Current Liabilities in data going back to fiscal Q4 2021.
- On a year-over-year basis, Total Current Liabilities rose in three of the last five quarters, with growth averaging 9.5%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 100.8% in fiscal Q1 2026, against a decline of 82.1% in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.51 million (Q3 2026), $2.59 million (Q2 2026) and $5.12 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 756,581.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 756,581.00 |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 2.59 Mn |
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Jun 30, 2023 | 2.76 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Jun 30, 2021 | 1.82 Mn |
API Access
Neuphoria Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();